Biopharma Reports Fifth Quarter of Increased Net Revenues
2023年5月16日 - 12:40AM
AllPennyStocks.com
Those afflicted with sickle cell disease face many challenges
and acute complications. This biopharma company is the leader in
treatment of the disease and just reported its fifth straight
increase...
To read the full story on AllPennyStocks.com, click
here.
Emmaus Life Sciences (NASDAQ:EMMA)
過去 株価チャート
から 4 2024 まで 5 2024
Emmaus Life Sciences (NASDAQ:EMMA)
過去 株価チャート
から 5 2023 まで 5 2024